Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study
- 8 November 2016
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 102, 108-117
- https://doi.org/10.1016/j.lungcan.2016.11.002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology StatementJournal of Clinical Oncology, 2015
- Lung Cancer Prognosis Before and After Recurrence in a Population-Based SettingJNCI Journal of the National Cancer Institute, 2015
- Leveraging State Cancer Registries to Measure and Improve the Quality of Cancer Care: A Potential Strategy for California and BeyondJNCI Journal of the National Cancer Institute, 2015
- Comprehensive Long-Term Care of Patients With Lung Cancer: Development of a Novel Thoracic Survivorship ProgramThe Annals of Thoracic Surgery, 2014
- Treatment of the postoperative recurrence of lung cancer in octogenariansSurgery Today, 2013
- Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: A systematic reviewLung Cancer, 2013
- Treatment of Non–Small Cell Lung Cancer in the Older PatientJournal of the National Comprehensive Cancer Network, 2012
- Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Prognostic Importance of Comorbidity in a Hospital-Based Cancer RegistryJAMA, 2004
- Consensus: the follow-up of the treated patientLung Cancer, 2003